Table 5 Antibody responses to SARS-CoV-2 in convalescent patients
From: Clinical characteristics of 134 convalescent patients with COVID-19 in Guizhou, China
Total N = 55 | Disease severity | P value | Age | P value | |||
|---|---|---|---|---|---|---|---|
Severe N = 6 | Non-severe N = 49 | Children N = 7 | Adults N = 48 | ||||
IgM (-),IgG (+) | 35 (63.6%) | 5 (83.3%) | 30 (61.2%) | 0.399 | 5 (71.4%) | 30 (62.5%) | > 0.99 |
IgM ( +),IgG (+) | 3 (5.5%) | 0 | 3 (6.1%) | > 0.99 | 0 | 3 (6.3%) | > 0.99 |
IgM (-),IgG (-) | 17 (30.9%) | 1 (16.7%) | 16 (32.7%) | 0.654 | 2 (28.6%) | 15 (31.3%) | > 0.99 |